| RS2128939599 |
FLNC
|
Health Risk |
Likely pathogenic |
— |
| RS2128939606 |
FLNC
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 5, Hypertrophic cardiomyopathy 26 |
| RS2128939610 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, FLNC-related disorder |
| RS2128939620 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
EGFR-related lung cancer, Hereditary cancer-predisposing syndrome |
| RS2128939622 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
EGFR-related disorder, Hereditary cancer-predisposing syndrome |
| RS2128940107 |
FLNC
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 5, Hypertrophic cardiomyopathy 26 |
| RS2128940130 |
FLNC
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 5, Hypertrophic cardiomyopathy 26 |
| RS2128940244 |
FLNC
|
Health Risk |
Pathogenic |
— |
| RS2128940259 |
FLNC
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 5, Hypertrophic cardiomyopathy 26 |
| RS2128940335 |
FLNC
|
Health Risk |
Likely pathogenic |
Myofibrillar myopathy 5, Hypertrophic cardiomyopathy 26 |
| RS2128940399 |
FLNC
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary familial dilated cardiomyopathy, Myofibrillar myopathy 5 |
| RS2128940685 |
FLNC
|
Health Risk |
Pathogenic |
— |
| RS2128942709 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
EGFR-related lung cancer, Hereditary cancer-predisposing syndrome |
| RS2128943032 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
EGFR-related lung cancer, Hereditary cancer-predisposing syndrome |
| RS2128946044 |
EGFR
|
Health Risk |
Likely pathogenic |
EGFR-related lung cancer, EGFR-related lung cancer |
| RS2128946276 |
EGFR
|
Health Risk |
Pathogenic |
Malignant tumor of urinary bladder, Malignant tumor of urinary bladder |
| RS2128946294 |
EGFR
|
Health Risk |
Pathogenic |
Malignant tumor of urinary bladder, Malignant tumor of urinary bladder |
| RS2128946456 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
EGFR-related lung cancer, Hereditary cancer-predisposing syndrome |
| RS2128946495 |
EGFR
|
Health Risk |
Pathogenic |
EGFR-related lung cancer, EGFR-related lung cancer |
| RS2128948223 |
EYA1
|
Health Risk |
Likely pathogenic |
Branchiootorenal syndrome 1, Branchiootorenal syndrome 1 |
| RS2128951023 |
ESCO2
|
Health Risk |
Pathogenic |
— |
| RS2128951038 |
ESCO2
|
Health Risk |
Pathogenic |
— |
| RS2128951088 |
ESCO2
|
Health Risk |
Pathogenic |
— |
| RS2128951089 |
ESCO2
|
Health Risk |
Pathogenic |
— |
| RS2128951110 |
ESCO2
|
Health Risk |
Pathogenic/Likely pathogenic |
Juberg-Hayward syndrome, Roberts-SC phocomelia syndrome |
| RS2128951189 |
ESCO2
|
Health Risk |
Pathogenic |
— |
| RS2128951191 |
ESCO2
|
Health Risk |
Pathogenic/Likely pathogenic |
Roberts-SC phocomelia syndrome, Juberg-Hayward syndrome |
| RS2128951192 |
ESCO2
|
Health Risk |
Pathogenic |
— |
| RS2128951206 |
ESCO2
|
Health Risk |
Pathogenic |
— |
| RS2128951232 |
ESCO2
|
Health Risk |
Pathogenic |
— |
| RS2128951287 |
ESCO2
|
Health Risk |
Pathogenic |
— |
| RS2128951366 |
ESCO2
|
Health Risk |
Pathogenic |
— |
| RS2128951424 |
EGFR
|
Health Risk |
Likely pathogenic |
EGFR-related lung cancer, EGFR-related lung cancer |
| RS2128951565 |
EYA1
|
Health Risk |
Likely pathogenic |
Branchiooculofacial syndrome, Branchiooculofacial syndrome |
| RS2128952254 |
ESCO2
|
Health Risk |
Pathogenic |
— |
| RS2128952376 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
EGFR-related lung cancer, Hereditary cancer-predisposing syndrome |
| RS2128952727 |
EGFR
|
Health Risk |
Likely pathogenic |
EGFR-related lung cancer, EGFR-related lung cancer |
| RS2128954790 |
EGFR
|
Health Risk |
Likely pathogenic |
Lung adenocarcinoma, Lung adenocarcinoma |
| RS2128955140 |
ESCO2
|
Health Risk |
Likely pathogenic |
— |
| RS2128955152 |
ESCO2
|
Health Risk |
Likely pathogenic |
Roberts-SC phocomelia syndrome, Roberts-SC phocomelia syndrome |
| RS2128955170 |
ESCO2
|
Health Risk |
Pathogenic |
— |
| RS2128956046 |
ESCO2
|
Health Risk |
Likely pathogenic |
— |
| RS2128957692 |
ESCO2
|
Health Risk |
Pathogenic |
Roberts-SC phocomelia syndrome, Roberts-SC phocomelia syndrome |
| RS2128958225 |
EGFR
|
Health Risk |
Pathogenic |
Malignant tumor of urinary bladder, Malignant tumor of urinary bladder |
| RS2128958231 |
EGFR
|
Health Risk |
Pathogenic |
EGFR-related lung cancer, EGFR-related lung cancer |
| RS2128958340 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
EGFR-related lung cancer, Hereditary cancer-predisposing syndrome |
| RS2128958651 |
EGFR
|
Health Risk |
Pathogenic |
EGFR-related lung cancer, EGFR-related lung cancer |
| RS2128958905 |
EGFR
|
Health Risk |
Likely pathogenic |
EGFR-related lung cancer, EGFR-related lung cancer |
| RS2128963917 |
CAMK2B
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS2128964427 |
EGFR
|
Health Risk |
Likely pathogenic |
Lung adenocarcinoma, Lung adenocarcinoma |
| RS2128964585 |
EGFR
|
Health Risk |
Pathogenic |
Malignant tumor of urinary bladder, Malignant tumor of urinary bladder |
| RS2128965514 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
EGFR-related lung cancer, Hereditary cancer-predisposing syndrome |
| RS2128965518 |
EGFR
|
Health Risk |
Pathogenic |
EGFR-related lung cancer, EGFR-related lung cancer |
| RS2128968646 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
EGFR-related lung cancer, Hereditary cancer-predisposing syndrome |
| RS2128968655 |
EGFR
|
Health Risk |
Pathogenic |
EGFR-related lung cancer, EGFR-related lung cancer |
| RS2128969775 |
EGFR
|
Health Risk |
Pathogenic |
EGFR-related lung cancer, EGFR-related lung cancer |
| RS2128969953 |
EGFR
|
Health Risk |
Pathogenic |
EGFR-related lung cancer, EGFR-related lung cancer |
| RS2128971690 |
EGFR
|
Health Risk |
Pathogenic |
EGFR-related lung cancer, EGFR-related lung cancer |
| RS2128972983 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
EGFR-related lung cancer, Hereditary cancer-predisposing syndrome |
| RS2128974636 |
TNPO3
|
Health Risk |
Likely pathogenic |
— |
| RS2128999571 |
BRAF
|
Health Risk |
Pathogenic |
Pineoblastoma, Pineoblastoma |
| RS2128999606 |
EYA1
|
Health Risk |
Pathogenic |
Melnick-Fraser syndrome, Melnick-Fraser syndrome |
| RS2128999627 |
EYA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Melnick-Fraser syndrome, Branchiootorenal syndrome 1 |
| RS2128999992 |
EYA1
|
Health Risk |
Likely pathogenic |
— |
| RS2129000083 |
EYA1
|
Health Risk |
Pathogenic |
Melnick-Fraser syndrome, Melnick-Fraser syndrome |
| RS2129000122 |
EYA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Melnick-Fraser syndrome, Branchiootic syndrome 1 |
| RS2129000653 |
EYA1
|
Health Risk |
Pathogenic |
Branchiootic syndrome 1, Branchiootic syndrome 1 |
| RS2129000663 |
EYA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Melnick-Fraser syndrome, Branchiootic syndrome 1 |
| RS2129015230 |
CLN8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2129015232 |
CLN8
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis 8, Neuronal ceroid lipofuscinosis 8 |
| RS2129015276 |
CLN8
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2129018408 |
BRAF
|
Health Risk |
Pathogenic |
Colorectal cancer, RASopathy |
| RS2129019628 |
BRAF
|
Health Risk |
Pathogenic |
Vascular malformation, Vascular malformation |
| RS2129023598 |
BRAF
|
Health Risk |
Likely pathogenic |
— |
| RS2129025227 |
EYA1
|
Health Risk |
Pathogenic |
Melnick-Fraser syndrome, Melnick-Fraser syndrome |
| RS2129031508 |
EYA1
|
Health Risk |
Pathogenic |
Melnick-Fraser syndrome, Melnick-Fraser syndrome |
| RS2129044284 |
BRAF
|
Health Risk |
Pathogenic/Likely pathogenic |
RASopathy, Noonan syndrome 7 |
| RS2129044317 |
BRAF
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, RASopathy |
| RS2129062565 |
DPP6
|
Health Risk |
Conflicting classifications of pathogenicity |
See cases, See cases |
| RS2129067294 |
AUTS2
|
Health Risk |
Pathogenic |
Autism spectrum disorder due to AUTS2 deficiency, Autism spectrum disorder due to AUTS2 deficiency |
| RS2129092780 |
KMT2C
|
Health Risk |
Likely pathogenic |
KMT2C-related disorder, KMT2C-related disorder |
| RS2129095098 |
KMT2C
|
Health Risk |
Pathogenic/Likely pathogenic |
Kleefstra syndrome 2, Kleefstra syndrome 2 |
| RS2129099779 |
KMT2C
|
Health Risk |
Likely pathogenic |
Kleefstra syndrome 2, Kleefstra syndrome 2 |
| RS2129101553 |
KMT2C
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2129112579 |
KMT2C
|
Health Risk |
Likely pathogenic |
Kleefstra syndrome 2, Kleefstra syndrome 2 |
| RS2129112621 |
KMT2C
|
Health Risk |
Pathogenic |
Kleefstra syndrome 2, Kleefstra syndrome 2 |
| RS2129114393 |
KMT2C
|
Health Risk |
Conflicting classifications of pathogenicity |
Kleefstra syndrome 2, Kleefstra syndrome 2 |
| RS2129115127 |
KMT2C
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder, Kleefstra syndrome 2 |
| RS2129115309 |
KMT2C
|
Health Risk |
Likely pathogenic |
— |
| RS2129117914 |
KMT2C
|
Health Risk |
Pathogenic |
— |
| RS2129119051 |
KMT2C
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2129119362 |
KMT2C
|
Health Risk |
Pathogenic |
Kleefstra syndrome 2, Kleefstra syndrome 2 |
| RS2129119384 |
KMT2C
|
Health Risk |
Likely pathogenic |
Kleefstra syndrome 2, Kleefstra syndrome 2 |
| RS2129119641 |
KMT2C
|
Health Risk |
Likely pathogenic |
Kleefstra syndrome 2, Kleefstra syndrome 2 |
| RS2129119932 |
KMT2C
|
Health Risk |
Pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2129120525 |
KMT2C
|
Health Risk |
Likely pathogenic |
Kleefstra syndrome 2, Kleefstra syndrome 2 |
| RS2129120710 |
KMT2C
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2129121010 |
KMT2C
|
Health Risk |
Pathogenic |
Kleefstra syndrome 2, Kleefstra syndrome 2 |
| RS2129124731 |
KMT2C
|
Health Risk |
Pathogenic |
Kleefstra syndrome 2, Kleefstra syndrome 2 |
| RS2129128809 |
KMT2C
|
Health Risk |
Likely pathogenic |
Kleefstra syndrome 2, Kleefstra syndrome 2 |